T45 Labs
Marwan Berrada-Sounni is an experienced leader in the MedTech industry, currently serving as Founder and Managing Director of T45 Labs, which focuses on developing minimally invasive cardiovascular technologies. Marwan is also the Founder and Chairman of NuevoSono, advancing next-generation intravascular ultrasound imaging, and the President, CEO, and co-founder of Advanced NanoTherapies, Inc., which specializes in drug-coated balloons utilizing biodegradable nanoparticle technology. Additionally, Marwan co-founded VahatiCor Inc. to address refractory angina and holds the position of Chief Business Officer at NEXSTEP MEDICAL, working on innovative devices for peripheral arterial disease. Previous roles include significant positions at Life Science Angels, Shifamed, Cleveland Clinic's Global Cardiovascular Innovation Center, Agile MV, and Bavaria Medical Technology, complemented by an education in Mechanical Engineering and an MBA in Finance from the University of Minnesota and McGill University, respectively.
This person is not in any teams
This person is not in any offices
T45 Labs
T45 Labs is a MedTech Incubator based in Silicon Valley, specializing in developing minimally invasive technologies for the cardiovascular market. Our strategy focuses on minimizing risks and maximizing returns through a fast-follower approach. We manage the T45 Fund I, a direct investment vehicle supporting Series A and Series B stages in our portfolio companies. Our team comprises experienced executives and engineers, leveraging their expertise in MedTech investments and development to drive innovation.